HVR Cardio
HVR Cardio develops the CathHELIX system, a transcatheter mitral repair technology designed to treat mitral valve regurgitation. The device reduces the mitral annulus by deploying a self-securing ring to the atrial and ventricular sides to restore native leaflet function. The system is intended for use in minimally invasive cardiovascular procedures to support positive ventricular remodeling.
Visit websiteEspoo, Finland
Healthtech
Medical Devices
Cardiovascular
Funding summary
- Total raised
- €11.1M
- Funding rounds
- 1
Investors in HVR Cardio
Investors on record for HVR Cardio. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like HVR Cardio?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors